Alain Pruvost

3.3k total citations
80 papers, 2.2k citations indexed

About

Alain Pruvost is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Alain Pruvost has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 23 papers in Molecular Biology and 19 papers in Virology. Recurrent topics in Alain Pruvost's work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (19 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Alain Pruvost is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (19 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Alain Pruvost collaborates with scholars based in France, United States and Spain. Alain Pruvost's co-authors include Henri Bénech, Jacques Grassi, François Bécher, Cécile Goujard, Frédéric Théodoro, Eugènia Negredo, Éric Ezan, Aloı̈se Mabondzo, Bonaventura Clotet and Jordi Puig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Alain Pruvost

78 papers receiving 2.2k citations

Peers

Countries citing papers authored by Alain Pruvost

Since Specialization

Citations

This map shows the geographic impact of Alain Pruvost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Pruvost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Pruvost more than expected).

Fields of papers citing papers by Alain Pruvost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Pruvost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Pruvost. The network helps show where Alain Pruvost may publish in the future.

Co-authorship network of co-authors of Alain Pruvost

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Pruvost. A scholar is included among the top collaborators of Alain Pruvost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Pruvost. Alain Pruvost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A cancer immunoprofiling strategy using mass spectrometry coupled with bioorthogonal cleavage 2024 ·Chemical Science ·(unknown), (unknown), Alain Pruvost, Frédéric Théodoro, (unknown), Simon Specklin, Dimitri Kereselidze, Caroline Denis, Benoit Jégo, (unknown), Mathilde Keck, (unknown), Bertrand Kühnast, Davide Audisio, Charles Truillet, Frédéric Taran	2
2	Intergenerational effects on fertility in male and female mice after chronic exposure to environmental doses of NSAIDs and 17α-ethinylestradiol mixtures 2023 ·Food and Chemical Toxicology ·Pascal Philibert, Isabelle Stévant, Stephanie Déjardin, M Girard, Eli Sellem, (unknown), (unknown), (unknown), (unknown), Alain Pruvost, Françis Poulat, Brigitte Boizet‐Bonhoure	4
3	Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D) 2021 ·European Journal of Medicinal Chemistry ·(unknown), Saoussen Oueslati, Mohamed Benchekroun, (unknown), Sandrine Ventre, (unknown), (unknown), (unknown), (unknown), Pascal Retailleau, Agustín Jacinto Zavala, (unknown), (unknown), (unknown), Alain Pruvost, Thierry Naas, Bogdan I. Iorga, Robert H. Dodd, Kevin Cariou	17
4	Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system 2020 ·Nature Communications ·Grégoire Chevalier, Eleni Siopi, Laure Guenin‐Macé, Maud Pascal, Thomas Laval, Aline Rifflet, Ivo G. Boneca, Caroline Demangel, Benoît Colsch, Alain Pruvost, Emeline Chu‐Van, (unknown), François Leulier, Gabriel Lepousez, Gérard Eberl, Pierre‐Marie Lledo	247
5	Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites 2019 ·Nucleic Acids Research ·Jihane Basbous, Antoine Aze, Laurent Chaloin, (unknown), (unknown), Cyril Ribeyre, Marion Larroque, Caitlin Shepard, Baek Kim, Alain Pruvost, Jérôme Moreaux, Domenico Maiorano, Marcel Méchali, Angelos Constantinou	15
6	Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model 2019 ·Scientific Reports ·G. Le Roux, Rafika Jarray, Anne-Cécile Guyot, (unknown), (unknown), Frédéric Théodoro, (unknown), Alain Pruvost, Nicolas Tournier, Yulia Kiyan, Oliver Langer, F Yates, J.P. Deslys, Aloı̈se Mabondzo	44
7	In utero exposure to acetaminophen and ibuprofen leads to intergenerational accelerated reproductive aging in female mice 2019 ·Communications Biology ·Moïra Rossitto, M. Ollivier, Stephanie Déjardin, Alain Pruvost, Christine Brun, (unknown), (unknown), (unknown), Céline Keime, Bernard de Massy, Françis Poulat, Pascal Philibert, Brigitte Boizet‐Bonhoure	23
8	The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques 2018 ·Journal of Clinical Investigation ·Mireille Laforge, Ricardo Silvestre, Vasco Rodrigues, (unknown), L. Campillo-Gimenez, Shahul Mouhamad, Valérie Monceaux, Marie‐Christine Cumont, (unknown), Alain Pruvost, Anabela Cordeiro‐da‐Silva, Bruno Hurtrel, Guido Silvestri, A Senik, Jérôme Estaquier	25
9	Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy 2016 ·PMC ·Fares Bassil, Pierre‐Olivier Fernagut, Erwan Bézard, Alain Pruvost, Thierry Lesté-Lasserre, Quyen Q. Hoang, Dagmar Ringe, Gregory A. Petsko, Wassilios G. Meissner	2
10	Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry 2009 ·Journal of Chromatography B ·(unknown), Grégoire Wuerzner, Éric Ezan, Alain Pruvost	37
11	Specificity enhancement with LC‐positive ESI‐MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells 2007 ·Journal of Mass Spectrometry ·Alain Pruvost, Frédéric Théodoro, Luigi A. Agrofoglio, Eugènia Negredo, Henri Bénech	43
12	Biological monitoring of occupational exposure to di(2-ethylhexyl) phthalate: survey of workers exposed to plastisols 2007 ·International Archives of Occupational and Environmental Health ·R. Gaudin, (unknown), Alain Robert, P. Ducos, Alain Pruvost, Michael Levi, (unknown)	15
13	Sensitive and specific LC–ESI–MS/MS method for the determination of a styrylquinoline, BA011FZ041, a potent HIV anti-integrase agent, in rat plasma 2006 ·Journal of Chromatography B ·Alain Pruvost, (unknown), Fatima Zouhiri, (unknown), Henri Bénech	5
14	CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8 2004 ·Drug Metabolism and Disposition ·M. Delaforge, Alain Pruvost, Lionel Perrin, François André	38
15	Peripheral blood mononuclear cell counting using a DNA-detection-based method 2004 ·Analytical Biochemistry ·Henri Bénech, Frédéric Théodoro, (unknown), Nathalie Pagé, Dimitri Schlemmer, Alain Pruvost, Jacques Grassi, Jean-Robert Deverre	35
16	Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients 2003 ·AIDS ·François Bécher, Alain Pruvost, Dimitri Schlemmer, (unknown), (unknown), Jean François Delfraissy, Henri Bénech, Jacques Grassi	31
17	A strategy for liquid chromatography/tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells 2003 ·Journal of Mass Spectrometry ·François Bécher, Alain Pruvost, (unknown), Philippe Couerbe, Cécile Goujard, Valérie Boutet, Éric Ezan, Jacques Grassi, Henri Bénech	48
18	Liquid chromatography–tandem mass spectrometry assays for intracellular deoxyribonucleotide triphosphate competitors of nucleoside antiretrovirals 2003 ·Journal of Chromatography B ·(unknown), François Bécher, Alain Pruvost, Cécile Goujard, Jacques Grassi, Henri Bénech	52
19	Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral‐blood mononuclear cells using high‐performance liquid chromatography/tandem mass spectrometry 2002 ·Rapid Communications in Mass Spectrometry ·François Bécher, Alain Pruvost, Cécile Goujard, Catherine Guerreiro, (unknown), Jacques Grassi, Henri Bénech	83
20	Fully automated determination of eserineN-oxide in human plasma using on-line solid-phase extraction with liquid chromatography coupled with electrospray ionization tandem mass spectrometry 2000 ·Journal of Mass Spectrometry ·Alain Pruvost, (unknown), (unknown), Patrice Jaillon, J M Grognet, Henri Bénech	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact